Drug Discovery App CS WP
-
Chemoenzymatic N-glycan Conjugation Of Native mAbs Provides Homogeneous, Efficacious ADCs
9/3/2026
A chemoenzymatic two-stage protocol enables DAR2 ADCs from native, non-engineered mAbs via glycan remodeling at Asn-297 and copper-free click chemistry, with in vivo efficacy outperforming a comparable marketed ADC.
-
Bringing Novel ADC Formats Into The Clinic: AOC Process Development
9/3/2026
Antibody-oligonucleotide conjugates introduce conjugation and purification challenges that standard ADC process development wasn't designed to solve. This white paper details practical approaches for each.
-
AI Enabled Pharmaceutical Cocrystal Screening
9/3/2026
Cocrystal candidate screening is resource-intensive and prone to gaps. This paper examines how AI-based modeling, trained on more than 20,000 data points, can sharpen candidate prioritization without sacrificing scientific rigor.
-
EPR Pulsed Dipolar Spectroscopy For Structural Biology
8/31/2026
Discover how automated EPR pulsed dipolar spectroscopy measures protein dynamics, complements Cryo-EM and AlphaFold, and delivers crucial structural insights for drug discovery.
-
Accelerating Cell Therapy Discovery With High-Throughput Electroporation
7/31/2026
Discover how high-throughput electroporation-based screening can compress your CAR-T optimization timeline while delivering reproducible, scale-ready results across multiple donor samples.
-
Organ-On-A-Chip Technology Unlocks Patient-Derived Precision Medicine
6/25/2026
Personalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.
-
How Isogenic Organ-Chips Are Transforming The Future Of Research
6/25/2026
Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.
-
Shining A Light On Dark Data
6/11/2026
Centralizing data unlocks faster insights, reduces duplicated effort, and improves compliance. By overcoming silos and “dark data,” organizations can enable efficient search, reuse, and analysis.
-
Filling Gaps In Drug Discovery Pipelines: From Candidate To Clinic
6/5/2026
See how existing partnerships with NIH allowed the chance to bring together government, academic, and industry resources through strategic initiatives that streamline processes and maximize benefits.
-
Mammalian Expression
5/28/2026
See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges.